CELCUITY INC. (CELC) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -208.68M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | 142.96M USD | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-208.68M | (m) | (m) | $142.96M | (m) | (m) |
| 2026-03-31 | $-186.57M | (m) | (m) | $148.30M | (m) | (m) |
| 2025-12-31 | $-172.19M | (m) | (m) | $145.00M | (m) | (m) |
| 2025-09-30 | $-159.42M | (m) | (m) | $140.84M | (m) | (m) |
| 2025-06-30 | $-146.63M | (m) | (m) | $133.51M | (m) | (m) |
| 2025-03-31 | $-126.91M | (m) | (m) | $115.78M | (m) | (m) |
| 2024-12-31 | $-113.27M | (m) | (m) | $104.20M | (m) | (m) |
| 2024-09-30 | $-96.57M | (m) | (m) | $88.81M | (m) | (m) |
| 2024-06-30 | $-85.40M | (m) | (m) | $78.71M | (m) | (m) |
| 2024-03-31 | $-76.18M | (m) | (m) | $69.96M | (m) | (m) |
| 2023-12-31 | $-66.23M | (m) | (m) | $60.59M | (m) | (m) |
| 2023-09-30 | $-58.14M | (m) | (m) | $53.12M | (m) | (m) |
| 2023-06-30 | $-49.89M | (m) | (m) | $45.25M | (m) | (m) |
| 2023-03-31 | $-44.43M | (m) | (m) | $39.87M | (m) | (m) |
| 2022-12-31 | $-39.39M | (m) | (m) | $35.29M | (m) | (m) |
| 2022-09-30 | $-34.07M | (m) | (m) | $30.18M | (m) | (m) |
| 2022-06-30 | $-29.03M | (m) | (m) | $25.52M | (m) | (m) |
| 2022-03-31 | $-33.07M | (m) | (m) | $30.22M | (m) | (m) |
| 2021-12-31 | $-28.36M | (m) | (m) | $25.76M | (m) | (m) |
| 2021-09-30 | $-24.59M | (m) | (m) | $22.37M | (m) | (m) |
| 2021-06-30 | $-21.47M | (m) | (m) | $19.38M | (m) | (m) |
| 2021-03-31 | $-10.04M | (m) | (m) | $8.07M | (m) | (m) |
| 2020-12-31 | $-9.56M | (m) | (m) | $7.68M | (m) | (m) |
| 2020-09-30 | $-8.90M | (m) | (m) | $7.07M | (m) | (m) |
| 2020-06-30 | $-8.51M | (m) | (m) | $6.82M | (m) | (m) |
| 2020-03-31 | $-8.14M | (m) | (m) | $6.53M | (m) | (m) |
| 2019-12-31 | $-7.81M | (m) | (m) | $6.27M | (m) | (m) |
| 2019-09-30 | $-7.86M | (m) | (m) | $6.41M | (m) | (m) |
| 2019-06-30 | $-7.74M | (m) | (m) | $6.29M | (m) | (m) |
| 2019-03-31 | $-7.83M | (m) | (m) | $6.37M | (m) | (m) |
| 2018-12-31 | $-7.93M | (m) | (m) | $6.33M | (m) | (m) |
| 2018-09-30 | $-7.81M | (m) | (m) | $6.09M | (m) | (m) |
| 2018-06-30 | $-7.36M | (m) | (m) | $5.86M | (m) | (m) |
| 2018-03-31 | $-7.04M | (m) | (m) | $5.62M | (m) | (m) |
| 2017-12-31 | $-5.95M | (m) | (m) | $4.98M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-3.33M | (m) | (m) | $3.06M | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |